Biotech

All Articles

ArsenalBio elevates $325M, pivots away from past lead possession

.Collection Biosciences is carrying on up. The tissue therapy provider has actually added $325 thous...

Lilly- backed weight-loss biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' marijuana make use of drug flunks phase 2b, driving Indivior to reassess $100M choice

.Aelis Farma's chances of getting a fast, favorable decision on a $100 thousand alternative repaymen...

ProKidney standstills period 3 test certainly not required for cell treatment confirmation

.ProKidney has actually ceased some of a pair of stage 3 tests for its own tissue treatment for kidn...

Vaxcyte surges on 'magnificent' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what professionals named "impressive" period 1/2 information for its 31-valent pne...

Recursion's mind condition test shows little documentation of efficacy

.Recursion has actually discovered through a very early exam of its own tech-enabled strategy to med...

Acepodia, Pfizer click all together for chemistry-based cell therapy

.Contact it a case of great chemistry: Acepodia, a biotech based on Nobel Champion science, is takin...

Praxis epilepsy medication decreases confiscations in stage 2 litigation

.Practice Preciseness Medicines has racked up yet another midphase gain in epilepsy this year, along...

Three directors resign as Dyne messages mixed information for DMD prospect

.After escaping a clinical hold numerous years back, Dyne Therapeutics has actually disclosed new pe...

Arrowhead fires off phase 3 data in rare metabolic condition before market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own hand before a potential face-off with Ionis, releas...